Calendar

Transgender teens and gender-affirming care: What reporters need to know

03/28/22    

webcast

SAVE THE DATE: March 28, 1 p.m. ET

As multiple states introduce legislation related to the care of transgender children and teens, it's becoming an even more important health care issue to cover, especially when so few people understand transgender health care or what gender-affirming care actually is.

View the webcast

Slides:
Legislative overview (898 KB .pdf)
Joshua Safer (791 KB .pdf)

Join us for a webinar with two experts, Dr. Jason Rafferty, a pediatrician and child psychiatrist who authored the American Academy of Pediatrics recommendations for gender-affirming care in children and adolescents, and Dr. Joshua Safer, a member of the Endocrine Society who serves as the Executive Director of the Mount Sinai Center for Transgender Medicine and Surgery in New York.

Learn what gender-affirming care involves, how hormone therapy works, how many teens actually receive hormone therapy, the short-term and long-term risks and benefits of hormone treatment, how fertility preservation works, common pitfalls and errors in transgender health care reporting, and the various misconceptions that exist about gender-affirming care before adulthood.

You'll also hear from an Endocrine Society representative who will review the confusing legislative landscape on this topic and leave with a list of websites, source recommendations, and other resources for reporting on this timely hot button issue.


Dallas Ducar


Jason Rafferty

Joshua Safer

Tara Haelle

  • Dallas Ducar is the founding CEO of Transhealth Northampton. Prior to assuming the CEO position, Dallas served as the Clinical Lead for Mental Health Services at the Massachusetts General Hospital Transgender Health Program, where she worked with an interdisciplinary team to provide novel gender-affirming care. Dallas worked to develop pathways for all patients to receive psychotherapy, psychopharmacology, and surgical assessments for life-saving interventions. Dallas is on faculty at Columbia University, Northeastern University, University of Virginia School of Medicine, University of Virginia School of Nursing, and the MGH Institute for Health Professions. She  serves on the Board of Directors for GLBTQ Legal Advocates and Defenders (GLAD) and of Healing Our Community Collaborative (HOCC). She also serves as the Vice-Chair of the Primary Care Alliance and is on the LGBTQI Federal Policy Roundtable.

  • Dr. Jason Rafferty is a board certified child psychiatrist and pediatrician at Thundermist Health Centers, Hasbro Children’s Hospital, and Emma Pendleton Bradley Hospital in Rhode Island.  He is a clinical assistant professor in the Department of Psychiatry and Human Behavior at the Warren Alpert Medical School of Brown University.  He graduated from Harvard Medical School and obtained post-graduate training through the Triple Board Residency at Brown University.  The Triple Board is a combined program in pediatrics, general psychiatry and child/adolescent psychiatry. He has additional degrees from Harvard University in public health concentrating on maternal and child health, and education focused on adolescent development and psychology.  He is involved with the American Academy of Pediatrics (AAP), frequently reviewing policy and publications related to LGBTQ health. He was recently the lead author of the AAP’s policy statement, “Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents.”

  • Joshua Safer is the executive director of the Mount Sinai Center for Transgender Medicine and Surgery in New York City and professor of medicine at the Icahn School of Medicine at Mount Sinai. Dr. Safer was the inaugural president of the United States Professional Association for Transgender Health (USPATH). Dr. Safer serves as medical curriculum lead for the Global Education Institute (GEI) of the World Professional Association for Transgender Health (WPATH) and has been a scientific co-chair for WPATH international meetings. Dr. Safer is a co-author of the Endocrine Society guidelines for the medical care of transgender patients, the transgender hormone treatment sections for UpToDate, the current transgender medical care review in the New England Journal of Medicine and the current review of transgender medical care in Annals of Internal Medicine.

    Dr. Safer graduated medical school at the University of Wisconsin-Madison, completed residency in Internal Medicine at Mount Sinai Beth Israel Medical Center in New York City, and completed fellowship in endocrinology at the Harvard-Longwood program based at Beth Israel Deaconess Medical Center in Boston.